Építés alatt – nem éles oldal
Belépés
BefejeződöttFázis nélkül

Difference in Postprandial Blood Glucose Levels Following the Consumption of Isoglucidic Amounts of Milk With Different Lactose Contents in Individuals With Type 1 Diabetes

A legfontosabb adatok

Ki végzi
Pontificia Universidad Catolica de Chile
Hol
Chile1 helyszín, 1 országbanVálassz országot a helyszínekhez
Azonosító
Állapot
Befejeződött
Résztvevők
14 fő vett részt
Kezdés
2023. máj. 11.
Befejezés
2024. dec. 30.
A vizsgálat típusa
Beavatkozással járó
A vizsgált kezelések
  • Milk Consumption (Cow's, Lactose-Free Cow's, Goat's, and Donkey's Milk).
A regiszteradat frissítve
2026. november 16.

Ki vehet részt

Életkor
18 év – 65 év
Nem
Nők és férfiak
Egészséges önkéntesek
Nem vehetnek részt

A regiszter feltételei, szó szerint

Mind a 9 feltétel megnézéseKevesebb

Ki vehet részt

  • Insulin pump users
  • Age over 18 years
  • No physical exercise during the 24 hours preceding the study
  • No active insulin remaining from a previous bolus (participants must be fasting or must have eaten breakfast sufficiently early)

Ki nem vehet részt

  • Food allergies and/or intolerances to the products under study
  • Malabsorptive diseases (Crohn's disease or active celiac disease)
  • Short bowel syndrome
  • Poor glycemic control
  • Gastrointestinal symptoms following food consumption

Hol van ez a vizsgálat?

Egy országban van helyszíne. Válassz országot, hogy lásd a helyszíneket.

A vizsgálatról

Mit akar kideríteni a vizsgálat

Only 2 out of 10 individuals meet the recommended dairy intake. This may be partly attributed to the high prevalence of lactose intolerance, which has led to an increased demand for lactose-free products. However, lactose-free milk contains high levels of its constituent monosaccharides (glucose and galactose), which increase its glycemic index (GI). GI is a key parameter in the dietary management of individuals with type 1 diabetes (T1D), as it helps guide food selection to achieve better glycemic control.

A teljes eredeti leírásKevesebb

Emerging types of milk available on the market, such as goat and donkey milk, are naturally low in lactose and may represent lower-GI alternatives to lactose-free cow's milk. However, neither their GI nor their glycemic response in individuals with T1D has been evaluated.

Objective: To compare the GI in healthy individuals and the glycemic response in individuals with T1D following the consumption of donkey, goat, and cow's milk, with and without lactose.

Hypothesis: Donkey and goat milk have a lower GI in healthy individuals and elicit a lower glycemic response in individuals with T1D compared with regular and lactose-free cow's milk.

Methods: The GI in healthy individuals and the glycemic response in individuals with T1D will be determined following the consumption of regular cow's milk, lactose-free cow's milk, goat milk, and donkey milk, according to ISO 26642:2010. Each milk sample will provide 25 g of available carbohydrates and will be compared with a reference food (glucose solution).

Expected Results: Emerging types of milk are expected to have a lower GI than lactose-free cow's milk. Additionally, goat and donkey milk consumption is expected to result in a lower glycemic response than lactose-free cow's milk in individuals with T1D.

A vizsgálat csoportja

  • Study Population: Adults with Type 1 Diabetes (T1D)A vizsgált kezelés

    The study included a single group of participants, all of whom consumed four different types of milk on separate study days. The order of administration was determined by individual participant preference, without randomization or predefined treatment sequences. Therefore, the Interventional Study Model has been revised to "Single Group Assignment" to accurately reflect the study procedures. The four milk types remain registered as separate interventions. Each arm can correspond to a milk: * Arm 1: Milk Type A * Arm 2: Milk Type B * Arm 3: Milk Type C * Arm 4: Milk Type D

    Kezelés: Milk Consumption (Cow's, Lactose-Free Cow's, Goat's, and Donkey's Milk).

Adatok és források

Regiszteradat
Szerepel a ClinicalTrials.gov-on.
A regiszteradat frissítve
2026. november 16.